Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
February 09, 2024 10:45 ET
|
Ambu A/S
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu...
GRANT OF PERFORMANCE SHARE UNITS
February 06, 2024 08:41 ET
|
Ambu A/S
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February...
INTERIM REPORT FOR Q1 2023/24
January 30, 2024 01:00 ET
|
Ambu A/S
In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth...
ANNUAL REPORT 2022/23 (EARNINGS RELEASE)
November 08, 2023 01:08 ET
|
Ambu A/S
For the full 2022/23 financial year, Ambu reported 7.6% organic revenue growth. This was driven by Endoscope Solutions posting 15% organic growth, the main drivers being urology and ENT growing high...
AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR
November 08, 2023 01:01 ET
|
Ambu A/S
Today, Ambu announces its financial guidance for the fiscal year 2023/24. Also, today, Ambu will publish its Q4 and full-year earnings release along with its Annual Report, including the company’s...
AMBU APPOINTS NEW CHIEF FINANCIAL OFFICER
October 11, 2023 02:36 ET
|
Ambu A/S
Thomas Frederik Schmidt will step down as CFO of Ambu by 31 December 2023; Henrik Skak Bender named as new CFO, effective 1 January 2024. Ambu A/S has appointed Henrik Skak Bender as the...
AMBU ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FISCAL YEAR 2022/23
October 09, 2023 06:59 ET
|
Ambu A/S
Today, Ambu announces its preliminary financial 2022/23 results. For the financial year 2022/23, EBIT before special items totalled DKK 302m, with an EBIT margin before special items of 6.3% (previous...
AMBU FINANCIAL CALENDAR FOR 2023/24
September 29, 2023 04:59 ET
|
Ambu A/S
This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 2023 8...
INTERIM REPORT FOR Q3 2022/23
August 31, 2023 01:01 ET
|
Ambu A/S
In Q3 2022/23, Ambu delivered 8% organic revenue growth and a 7.6% EBIT margin. This was driven by Endoscopy Solutions growing 23%, due to high double-digit growth within urology and ENT, and...
Grant of Performance Share Units and reporting of transactions in accordance with Article 19 of the Market Abuse Regulation
July 28, 2023 10:46 ET
|
Ambu A/S
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 198,872 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2022/23 have been granted on 28 July...